Provided by Tiger Fintech (Singapore) Pte. Ltd.

Milestone Pharmaceuticals Inc.

0.8001
-0.0799-9.08%
Post-market: 0.7897-0.0104-1.30%19:59 EDT
Volume:5.14M
Turnover:4.19M
Market Cap:42.69M
PE:-1.06
High:0.8800
Open:0.8800
Low:0.7800
Close:0.8800
Loading ...

BUZZ-U.S. STOCKS ON THE MOVE-GameStop, Oxford Industries, Wolfspeed

Reuters
·
29 Mar

Milestone Pharmaceuticals Price Target Maintained With a $25.00/Share by HC Wainwright & Co.

Dow Jones
·
29 Mar

Dow Tumbles Over 500 Points; Abacus Global Management Shares Spike Higher

Benzinga
·
29 Mar

Piper Sandler Adjusts Price Target on Milestone Pharmaceuticals to $4 From $5, Maintains Overweight Rating

MT Newswires Live
·
28 Mar

Milestone Pharmaceuticals Shares Down 64.7% After FDA Declines to Approve Co's Heart Rhythm Nasal Spray

THOMSON REUTERS
·
28 Mar

BRIEF-FDA Issues Complete Response Letter For Etripamil For PSVT

Reuters
·
28 Mar

BUZZ-Milestone Pharma slumps after FDA declines to approve heart rhythm nasal spray

Reuters
·
28 Mar

Milestone Pharmaceuticals Shares Down 60% Premarket After FDA Declines to Approve Co's Heart Rhythm Nasal Spray

THOMSON REUTERS
·
28 Mar

FDA Rejects Milestone Pharmaceuticals' Etripamil Nasal Spray

Dow Jones
·
28 Mar

US FDA declines to approve Milestone Pharma's heart rhythm nasal spray

Reuters
·
28 Mar

Milestone Pharmaceuticals Inc - Inspection Required at Facility Performing Etripamil Release Testing

THOMSON REUTERS
·
28 Mar

Milestone Pharmaceuticals Inc - FDA Raises No Concerns on Etripamil Clinical Safety or Efficacy

THOMSON REUTERS
·
28 Mar

Milestone Pharmaceuticals Inc - Company to Submit Additional Info on Nitrosamine Impurities

THOMSON REUTERS
·
28 Mar

FDA Issues Complete Response Letter for Etripamil for PSVT

GlobeNewswire
·
28 Mar

Milestone Pharmaceuticals Inc - Enters Amended and Restated Open Market Sale Agreement With Jefferies - SEC Filing

THOMSON REUTERS
·
19 Mar

Milestone Pharmaceuticals Price Target Maintained With a $25.00/Share by HC Wainwright & Co.

Dow Jones
·
17 Mar